- Home
- GEVO vs SRZN Comparison
GEVO vs SRZN Comparison
Compare GEVO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEVO | SRZN |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.1M | 356.0M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | GEVO | SRZN |
|---|---|---|
| Price | $1.86 | $25.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.58 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 3.3M | 66.5K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $711,000.00 | N/A |
| Revenue This Year | $19.44 | $75.35 |
| Revenue Next Year | $5.59 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.10 | $7.95 |
| 52 Week High | $2.97 | $35.00 |
Technical Indicators
Market Signals| Indicator | GEVO | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 52.45 | 37.47 |
| Support Level | $1.59 | $24.16 |
| Resistance Level | $1.89 | $29.18 |
| Average True Range (ATR) | 0.09 | 1.89 |
| MACD | 0.02 | -0.44 |
| Stochastic Oscillator | 82.26 | 10.67 |
Price Performance
Historical ComparisonAbout GEVO Gevo Inc.
Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).